Skip to main content
. 2021 Dec;12(6):3061–3078. doi: 10.21037/jgo-21-748

Table 3. The kinase, miRNA and transcription factor-target networks of EIF2S2 in HCC (LinkedOmics).

Enriched category Geneset LeadingEdgeNum P value FDR
Kinase target Kinase_MAPK1 54 0 0.31931
Kinase_MAP3K6 1 0.0042918 0.30758
Kinase_DYRK1A 7 0.0043668 0.35358
Kinase_CSNK2A1 84 0.0068493 0.63526
Kinase_PIM1 8 0.011765 0.29544
miRNA target ATACTGT, MIR-144 59 0 0
TAGGTCA, MIR-192, MIR-215 17 0 0
TGTTTAC, MIR-30A-5P, MIR-30C, MIR-30D, MIR-30B, MIR-30E-5P 184 0 0
TACTTGA, MIR-26A, MIR-26B 82 0 0
GCTTGAA, MIR-498 33 0 0
Transcription factor target GGAANCGGAANY_UNKNOWN 38 0 0
V$FREAC2_01 60 0 0
YNGTTNNNATT_UNKNOWN 79 0 0
V$FREAC4_01 42 0 0.000724
V$FOXO4_02 75 0 0.000905

V$, the annotation found in Molecular Signatures; Database (MSigDB) for transcription factors (TF). EIF2S2, eukaryotic translation initiation factor 2 subunit beta; HCC, hepatocellular carcinoma; LeadingEdgeNum, the number of leading edge genes; FDR, false discovery rate from Benjamini and Hochberg from gene set enrichment analysis (GSEA).